Meyka Pro banner
Delcath Systems, Inc.

Delcath Systems, Inc. (DCTH) Stock Overview

Explore Delcath Systems, Inc.’s financial performance, market position, analyst ratings, and future outlook.

DCTHNASDAQ
HealthcareMedical - Devices
$17.14
$0.39(2.33%)
U.S. Market opens in 60h 42m

Delcath Systems, Inc. (DCTH)

Meyka AI Score

Z

Key Financials

Market Cap591.7M
P/E Ratio1540.13
EPS (TTM)$0.01
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$18.76
3 Months$8.52
1 Year Target$12.46

DCTH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Delcath Systems, Inc. (NASDAQ: DCTH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Delcath Systems, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DCTH on the NASDAQ shows an RSI of 67.52, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.46 for the NASDAQ listing.

Key metrics behind Delcath Systems, Inc.'s NASDAQ-traded stock include a P/E ratio of 1540.13 and a market capitalization of 591.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DCTH on the NASDAQ.

Price Performance (NASDAQ: DCTH)

1-Day Change
2.33%
5-Day Change
-0.92%
1-Month Change
33.80%
3-Month Change
49.69%
6-Month Change
75.26%
Year-to-Date (YTD) Change
69.70%
1-Year Change
64.65%
3-Year Change
237.40%
5-Year Change
92.58%
All-Time (Max) Change
-98.19%

Contact Information

212 489 2100
566 Queensbury Avenue, Queensbury, NY, 12804

Company Facts

1,560 Employees
IPO DateMay 3, 2018
CountryUS
Actively Trading

Frequently Asked Questions